SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

A project grown out of the community's love and passion for the weed culture. Launched around early 2025, $weedcoin, “Like Bitcoin but way higher,” emphasizes its alignment with cannabis culture and a laid-back vibe. Unlike other Weed communities, this project leans heavily into community engagement over technical utility, aiming to build a “stoner community” through social media presence and decentralized governance. We also aim to focus on onboarding web2 businesses and users onto web3 through the token.

Weedcoin

Weedcoin is trending as its community rallies in anticipation of the upcoming 4/20 cultural event, with proponents highlighting its "culture first" mission to advance global cannabis legalization on the Solana blockchain, framing it as "like Bitcoin but way higher" amidst discussions of both potential and skepticism.

Schwab Strategic Trust - Schwab US Dividend Equity ETF

Schwab US Dividend Equity ETF

Schwab US Dividend Equity ETF (SCHD) is gaining significant attention and showing strong resilience, often posting gains even as broader markets experience downturns, cementing its perception as a "flight to safety" asset. The community is actively discussing its consistent dividend growth and potential benefits from sector rotation away from tech, though some investors anticipate a pullback due to an extended valuation.

Abeona Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development of gene therapy for severe and life-threatening rare diseases. It programs include EB-101 (gene-corrected skin grafts) for recessive dystrophic epidermolysis bullosa (RDEB), ABO-102 (AAV-SGSH), an adeno-associated virus (AAV) based gene therapy for Sanfilippo syndrome type A (MPS IIIA), and ABO-101 (AAV NAGLU), an AAV based gene therapy for Sanfilippo syndrome type B (MPS IIIB). The company was founded in 1974 and is headquartered in Cleveland, OH.

Abeona Therapeutics Inc

Abeona Therapeutics is trending as it announced its first commercial ZEVASKYN patient treatment and secured a permanent J-code for smoother reimbursement, reinforcing its projected path to profitability in the first half of 2026. The community highlights the stock's deep undervaluation against its cash position and immense revenue potential, fueling speculation of a re-rating as patient treatments for the rare disease gene therapy ramp up.

Lowe's Companies, Inc. engages in the retail sale of home improvement products. The firm offers products for maintenance, repair, remodeling, home decorating, and property maintenance. It also provides home improvement products in the following categories: appliances, seasonal & outdoor living, lumber, lawn & garden, kitchens & bath, hardware, building materials, millwork, paint, rough plumbing, tools, electrical, flooring, and décor. The company was founded in 1946 and is headquartered in Mooresville, NC.

Lowe`s Cos., Inc.

Lowe's Companies, Inc.

Lowe's is seeing increased conversation after its Q4 earnings outperformed expectations, fueled by a return to positive comparable sales and robust Pro segment growth, which offsets persistent DIY and housing market pressures. The company's strategic acquisition of Foundation Building Materials and cautious guidance for the upcoming year are leading to community debate about its resilience and competitive positioning against Home Depot.

FMC Corp. is an agricultural sciences company, which engages in the provision of solutions to growers and development of pipeline in crop protection, plant health, agriculture, pest control, and turf management. It offers insect control products under the Rynaxypyr and Cyazypyr brands, herbicides under the Authority, Boral, Centium, Command, and Gamit brands, insecticides under the Talstar and Hero brands, flutriafol-based fungicides, and bionematicides under the Quartzo and Presence brands. The company was founded by John Bean in 1883 and is headquartered in Philadelphia, PA.

FMC Corp.

FMC Corporation is trending after reporting a significant Q4 earnings and revenue miss, paired with a substantial dividend cut and the initiation of a strategic review including a potential sale, leading to widespread community debate over its high debt and future viability as an oversold value play or a deeper value trap.

The Home Depot, Inc. engages in the sale of building materials and home improvement products. Its products include building materials, home improvement products, lawn and garden products and decor products. The firm operates through the following geographical segments: U.S., Canada and Mexico. It offers home improvement installation services, and tool and rental equipment. The company was founded by Bernard Marcus, Arthur M. Blank, Kenneth Gerald Langone and Pat Farrah on June 29, 1978 and is headquartered at Atlanta, GA.

Home Depot, Inc.

Home Depot is trending following a downward revision to its full-year outlook after missing Q3 earnings, citing soft big-ticket demand and macroeconomic headwinds, which is intensifying community debate around its short-term trajectory despite ongoing strategic investments in its Pro ecosystem and digital initiatives.

Harrow, Inc. engages in the development, production, and sale of innovative medications. It operates through the following segments: Pharmaceutical Compounding and Pharmaceutical Drug Development. The Pharmaceutical Compounding segment focuses on the operations of the ImprimisRx business. The company was founded by Mark L. Baum and Robert J. Kammer on January 11, 2006 and is headquartered in Nashville, TN.

Harrow Inc

Harrow Health Inc

Harrow Health Inc. is trending due to its reaffirmed FY25 outlook and strong VEVYE script growth, which is significantly boosted by recent CVS Caremark Tier 1 formulary status. This has ignited community discussion about the company's substantial long-term potential and the likelihood of a short squeeze, with many investors actively calling it undervalued.

OpenAI pioneers large-language models like GPT and DALL·E, enabling advanced AI applications. Their research emphasizes both cutting-edge capability and responsible deployment strategies.

OpenAI PreStocks

OPENAI CRYPTO is trending due to overwhelming community confusion and skepticism, with many users questioning its legitimacy as a potential scam and differentiating it from the actual OpenAI AI company.

Genius Sports Ltd. engages in the provision of scalable, technology-led products and services to the sports, sports betting, and sports media industries. It also involves in Sports League, which offers technology infrastructure for the collection, integration, and distribution of live data; Sportsbooks, which includes collection of live sports data, odds making, risk management and player marketing; and Sports Media, which provides a range of online marketing and fan engagement tools. The company was founded by Mark Adrian Locke in 2000 and is headquartered in London, United Kingdom.

Genius Sports Limited

Genius Sports is trending due to widespread investor frustration following its $1.2 billion acquisition of Legend, with the community questioning the high price, increased debt, and strategic rationale for a seemingly obscure media company. While management touts the deal as transformational for international growth and a play on prediction markets, many shareholders view it as an overpay that introduces new risks and damages trust after recent promises of focusing on shareholder value.

BtcUSD is a completely decentralized stablecoin issued and managed by BTCFi, a platform where users can deposit Bitcoin of various formats to use as collaterals. BtcUSD offers Bitcoin holders the opportunity to generate additional yields with their Bitcoin positions through DeFi usage.

Bitcoin USD (BTCFi)

Bitcoin is experiencing highly volatile trading, prompting fierce community debate over whether its rebound from recent lows signals a sustained rally or a temporary bounce. Traders are closely watching key technical levels and institutional flows for direction amidst broader market uncertainty.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Should You Invest in the Pacer Data and Digital Revolution ETF (TRFK)?

ETFs to Buy as Intel Plunges 17% Despite Q4 Earnings Beat 

INTC shares plummet 17% after Q4 earnings release as weak Q1 guidance rattled investors, pushing Intel-heavy ETFs into focus for diversified exposure.  

<ul class="summary-bullets"><li>As per a Reuters report, the bondholders who purchased $18 billion of the company’s notes issued in Sept. 2025, were blindsided when the company went back for another $38 billion of ‍loans just seven weeks later.</li><li>The Sept. 2025 bond sale came just two weeks after ‍Oracle signed a $300 billion deal with OpenAI to provide computing power over about five years.&nbsp;</li><li>Meanwhile, technology companies in the U.S. declined on Tuesday.</li></ul><p>Shares of Oracle Corp. (ORCL) slumped over 5% on Wednesday after a bondholder lawsuit that claimed suffering losses over the company’s failure to disclose the need to issue substantial debt to scale its artificial intelligence infrastructure.</p><p>The slump in <a href="https://stocktwits.com/symbol/ORCL">ORCL shares</a> came amid a broader decline of tech stocks, with the tech-heavy Nasdaq 100 declining over 1.5% at the time of writing.</p><h2 class="st-heading-2">Lawsuit Details</h2><p>The proposed lawsuit, filed in a New York state court in Manhattan, according to a Reuters <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.reuters.com/sustainability/boards-policy-regulation/oracle-sued-by-bondholders-over-losses-tied-ai-buildout-2026-01-14/">report</a>, was on ​behalf of bondholders who purchased $18 billion of notes and bonds that the company issued in Sept. 2025.</p><p>The bond sale came just two weeks after ‍Oracle signed a $300 billion deal with OpenAI to provide computing power over about five years. The investors claimed they were blindsided when the company went back for another $38 billion of ‍loans just seven weeks later to bankroll two additional data centers to support the OpenAI agreement.</p><p>The complaint held the company, ​chairman and co-founder Larry Ellison, former CEO Safra Catz, Chief Accounting Officer Maria Smith, and Oracle’s underwriters strictly liable for false and misleading statements in the $18 billion debt sale’s offering documents, as per Reuters.</p><p>The bondholders are seeking unspecified damages, as per the report.</p><h2 class="st-heading-2">Tech Selloff</h2><p>Meanwhile, technology companies declined on Tuesday.</p><p>Chip stocks like Broadcom Inc. (AVGO), Nvidia Corp. (NVDA), and Micron Technology (MU) fell over 4.5%, 1.8% and 2% respectively amid a broader sell off.</p><h2 class="st-heading-2">How Did Stocktwits Users React?</h2><p>On Stocktwits, retail sentiment around ORCL shares remained in the ‘bearish’ territory over the past day amid ‘low’ message volumes.</p><figure class="image"><img src="https://news.stocktwits-cdn.com/Screenshot_2026_01_15_at_1_45_05_AM_png_5d3a69db14.webp" alt="On Stocktwits, retail sentiment around ORCL shares remained in the ‘bearish’ territory over the past day amid ‘low’ message volumes." width="1284" height="155"></figure><p>&nbsp;</p><p>Shares of ORCL have gained over 22% in the past year.</p><p><i>For updates and corrections, email newsroom[at]stocktwits[dot]com.</i></p><p>&nbsp;</p>

The Oracle logo is displayed on a mobile phone with the company's branding seen in the background in this photo illustration.

Why Is ORCL Stock Falling Today?

Oracle faced a bondholder lawsuit on Wednesday that claimed suffering losses over the company’s failure to disclose the need to issue substantial debt to scale its artificial intelligence infrastructure.

Equity

Worried About Oracle's Downfall? Hedge With These 5 Top-Ranked Tech ETFs

Oracle's selloff, tied to AI spending and debt fears, has rattled investors. Diversifying with top tech ETFs like XLK could help mitigate single-stock risk.

ETFs to Watch as Oracle Dips Despite Beating on Q2 Earnings

ORCL's post-earnings slide opens a window for investors eyeing ETF exposure as the cloud giant beats profit expectations but misses on revenues. 

AI Supercharger: Why Is NVDA-ORCL-DOE Deal a Bull Signal for Tech ETFs?

Nvidia and Oracle's DOE-backed AI supercomputer project fuels optimism for tech ETFs, like TRFK and XLK, poised to ride the next wave of AI growth.  

The Zacks Analyst Blog Highlights Oracle, IGV, TRFK, TDIV and TDVI.

Oracle soars 36% on record cloud demand and RPO growth, boosting AI deals and Oracle-heavy ETFs.

Digital Revolution ETF (TRFK) Hits New 52-Week High

Digital Revolution ETF TRFK surges to a 52-week high, lifted by Oracle's spectacular cloud-driven rally and strong momentum signals.

Oracle's Monster Rally Puts These ETFs in Focus 

Oracle stock soars 36% on cloud demand and AI deals. ETFs like IGV, TRFK, TDIV and TDVI offer exposure.

Up 5%

Down 5%

Markets are hovering near key levels, making the next 5% move especially important for sentiment. A breakout higher could reinforce the bull case, while a 5% drop may signal rising risk and tighter conditions. Which comes first?

TRFK
Pacer Data & Digital Revolution ETF

Feed

News

Sentiment

Fundamentals

Info

Latest TRFK News

TRFKPacer Data & Digital Revolution ETF